US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Conexeu Sciences Inc.

8.57

-0.5800-6.34%

Post-market: 8.40-0.1673-1.95%19:34 EDT

Volume:61.90K

Turnover:545.79K

Market Cap:229.32M

PE:-31.86

High:9.15

Open:9.15

Low:8.50

Close:9.15

52wk High:18.79

52wk Low:8.14

Shares:26.76M

Float Shares:25.76M

Volume Ratio:0.55

T/O Rate:0.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2690

EPS(LYR):-0.3104

ROE:--

ROA:--

PB:31.87

PE(LYR):-27.61

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Conexeu Sciences Announces Press Release Availability

Conexeu Sciences Completes 12-month Preclinical Study for CXU Tissue-restoration Platform

Conexeu Sciences Notifies Availability of Press Release

Conexeu Sciences Director Andrew Costa Files Initial Beneficial Ownership Statement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CNXU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNXU\",,,,,undefined,":{"symbol":"CNXU","market":"US","secType":"STK","nameCN":"Conexeu Sciences Inc.","latestPrice":8.57,"timestamp":1784923200000,"preClose":9.15,"halted":0,"volume":61902,"hourTrading":{"tag":"盘后","latestPrice":8.4027,"preClose":8.57,"latestTime":"19:34 EDT","volume":461,"amount":3910.5954,"timestamp":1784936047744,"change":-0.1673,"changeRate":-0.019522,"amplitude":0.019522},"delay":0,"changeRate":-0.06338797814207651,"floatShares":25758300,"shares":26758300,"eps":-0.269,"marketStatus":"Market Closed","change":-0.58,"latestTime":"07-24 16:00:00 EDT","open":9.15,"high":9.15,"low":8.5,"amount":545789.841147,"amplitude":0.071038,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.269,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"listingDate":1779336000000,"exchange":"NASDAQ","adjPreClose":9.15,"postHourTrading":{"tag":"盘后","latestPrice":8.4027,"preClose":8.57,"latestTime":"19:34 EDT","volume":461,"amount":3910.5954,"timestamp":1784936047744,"change":-0.1673,"changeRate":-0.019522,"amplitude":0.019522},"volumeRatio":0.548047808037121},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNXU\",,,,,undefined,":{"symbol":"CNXU","floatShares":25758300,"roa":"--","roe":"--","lyrEps":-0.310358,"volumeRatio":0.548047808037121,"shares":26758300,"dividePrice":0,"high":9.15,"amplitude":0.071038,"preClose":9.15,"low":8.5,"week52Low":8.14,"pbRate":"31.87","week52High":18.7915,"institutionHeld":0,"latestPrice":8.57,"eps":-0.269,"divideRate":0,"volume":61902,"delay":0,"ttmEps":-0.269,"open":9.15,"prevYearClose":13.5,"prevWeekClose":9.83,"prevMonthClose":10.92,"prevQuarterClose":10.92,"fiveDayClose":9.83,"twentyDayClose":10.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNXU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNXU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNXU\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1782187200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNXU\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNXU","date":"2026-07-24","current":-31.858736,"percent":0.97619,"low":-79.55424,"twenty":-64.738738,"median":-41.558115,"eighty":-37.945013,"high":-33.008592,"avg":-50.567623,"sd":14.400423,"marketCap":244838719},"quantilePoints":[{"date":"2026-05-22","current":-61.707651,"twenty":-61.707651,"median":-61.707651,"eighty":-61.707651,"marketCap":330278847},{"date":"2026-05-29","current":-54.672884,"twenty":-65.607461,"median":-64.327983,"eighty":-60.300698,"marketCap":292626553},{"date":"2026-06-05","current":-75.541118,"twenty":-76.3343,"median":-65.838806,"eighty":-60.437616,"marketCap":404319936},{"date":"2026-06-12","current":-57.26961,"twenty":-72.783868,"median":-65.815199,"eighty":-60.63119,"marketCap":306525051},{"date":"2026-06-18","current":-61.471585,"twenty":-72.022319,"median":-64.327983,"eighty":-56.504756,"marketCap":329015347},{"date":"2026-06-26","current":-37.989619,"twenty":-69.581868,"median":-61.589618,"eighty":-54.125211,"marketCap":273470132},{"date":"2026-07-02","current":-38.138306,"twenty":-67.458218,"median":-61.182094,"eighty":-40.651122,"marketCap":274540465},{"date":"2026-07-10","current":-36.837292,"twenty":-66.325102,"median":-57.26961,"eighty":-39.424451,"marketCap":265175050},{"date":"2026-07-17","current":-39.067602,"twenty":-65.494149,"median":-53.988293,"eighty":-38.257256,"marketCap":281230048},{"date":"2026-07-24","current":-34.012232,"twenty":-64.738738,"median":-41.558115,"eighty":-37.945013,"marketCap":244838719}],"updateTime":1785088146526},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNXU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651110567","title":"Conexeu Sciences Announces Press Release Availability","url":"https://stock-news.laohu8.com/highlight/detail?id=2651110567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651110567?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:31","pubTimestamp":1784032311,"startTime":"0","endTime":"0","summary":"Conexeu Sciences announces press release availabilityConexeu released an update on its CXU tissue-restoration platform, citing completion of a 12-month P.R.O.O.F. preclinical study.Focus is large-volu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDLc1zG4s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNXU","SG9999014021.USD","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","SG9999014005.SGD","SG9999014013.SGD","BCDF","IE00B64PRP62.GBP","BK4585","IE00BGHQF748.EUR","BK4588","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4139","NDAQ","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4112","SG9999014039.USD","LU2210149790.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649195853","title":"Conexeu Sciences Completes 12-month Preclinical Study for CXU Tissue-restoration Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2649195853","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649195853?lang=en_us&edition=fundamental","pubTime":"2026-07-08 05:13","pubTimestamp":1783458831,"startTime":"0","endTime":"0","summary":"Conexeu Sciences completes 12-month preclinical study for CXU tissue-restoration platformConexeu completed its 12-month P.R.O.O.F preclinical study for the CXU platform, a key milestone ahead of plann","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL92bnq6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649938802","title":"Conexeu Sciences Notifies Availability of Press Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2649938802","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649938802?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:01","pubTimestamp":1783429306,"startTime":"0","endTime":"0","summary":"Conexeu Sciences notifies availability of press releaseConexeu published a release reporting completion of its 12-month P.R.O.O.F preclinical program for the CXU platform.Results met study objectives ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL8HbHGg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4588","SG9999014021.USD","IE00BN0W2T93.GBP","CNXU","BCDF","LU2210149790.SGD","IE00BGHQF748.EUR","BK4112","LU0314104364.USD","IE00BN0W2W23.USD","BK4139","BK4585","LU2210150020.SGD","IE00B64PRP62.GBP","NDAQ","SG9999014013.SGD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647378736","title":"Conexeu Sciences Director Andrew Costa Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2647378736","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647378736?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:15","pubTimestamp":1782728131,"startTime":"0","endTime":"0","summary":"Conexeu Sciences director Andrew Costa files initial beneficial ownership statementConexeu Sciences director Andrew Costa reported holding options to buy 50,000 common shares at USD 2.3 per share in a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL5Wm6lz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNXU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CNXU\",params:#limit:6,delay:false,,,undefined,":[]}}